Vivos Therapeutics (VVOS) Current Leases (2021 - 2026)
Vivos Therapeutics (VVOS) reported Current Leases of $744000.0 for Q1 2026, up 59.31% year-over-year from $467000.0 in Q1 2025, and up 10.71% quarter-over-quarter from $672000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Current Leases (2021 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 6 years of Current Leases data on file, last reported at $744000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $744000.0, up 59.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $744000.0 (up 59.31% YoY), and the FY2025 annual result was $672000.0, up 40.88% from the prior year.
- Current Leases improved to $744000.0 in Q1 2026 per VVOS's latest filing, from $672000.0 in the prior quarter.
- Over five years, Current Leases peaked at $744000.0 in Q1 2026 and troughed at $55000.0 in Q2 2025.
- A 5-year average of $471764.7 and a median of $467000.0 in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2025: Current Leases jumped 481.94% in 2022, then plunged 88.64% in 2025.
- A 5-year view of Current Leases shows it stood at $419000.0 in 2022, then gained by 13.13% to $474000.0 in 2023, then advanced by 0.63% to $477000.0 in 2024, then soared by 40.88% to $672000.0 in 2025, then increased by 10.71% to $744000.0 in 2026.
- Business Quant data shows VVOS's Current Leases at $744000.0 in Q1 2026, $672000.0 in Q4 2025, and $734000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 35.80 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 744,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 744,000.00 |
| Dec 31, 2025 | 672,000.00 |
| Sep 30, 2025 | 734,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 467,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | 485,000.00 |
| Jun 30, 2024 | 484,000.00 |
| Mar 31, 2024 | 483,000.00 |
| Dec 31, 2023 | 474,000.00 |
| Sep 30, 2023 | 460,000.00 |
| Jun 30, 2023 | 447,000.00 |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | 419,000.00 |
| Sep 30, 2022 | 446,000.00 |
| Jun 30, 2022 | 383,000.00 |
| Mar 31, 2022 | 357,000.00 |
| Dec 31, 2021 | 72,000.00 |